← Evidence map

ReviewCurrent treatment options in oncology2022

Regorafenib for the Treatment of Sarcoma.

Jean-Yves Blay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36178573